Circulating Tumor DNA Sequencing at Ayass Bioscience, LLC
Circulating Tumor DNA Sequencing at Ayass Bioscience, LLCLarisa2020-05-17T17:37:49-05:00
Circulating Tumor DNA (ctDNA) Sequencing
A New Generation of Cancer Biomarkers – Circulating Tumor DNA (ctDNA) Detection and Monitoring
Circulating tumor DNA (ctDNA) are fragments of DNA from dying cancer cells found in the blood of cancer patients. At Ayass BioScience, we utilize a minimally invasive method (alternative to risky and invasive tumor biopsies) that requires only a few milliliters of plasma from patients to detect mutations in genes associated with cancer. ctDNA is detectable for most types of cancer and could be used as an effective screening method and as a way to monitor the response to therapeutic treatments for most patients.
NEXT GENERATION SEQUENCING – SOMATIC MUTATION
Our ctDNA panel targets 28 genes commonly found mutated in solid tumor type cancers. This assay is performed using cell free DNA isolated from human plasma specimens. The test is intended to identify the presence of circulating tumor DNA and identify mutations in genes associated with cancer. The test can be used for the monitoring of cancer remission after treatment such as chemotherapy, radiation or surgery.
ALK CTNNB1 ESR1 IDH2 MAP2K2 NTRK3 ROS1 AKT1 DDR2 FGFR1 KIT MET PIK3CA SMAD4 AR EGFR HRAS KRAS NRAS PDGFRA MTOR BRAF ERBB2 (HER2) IDH1 MAP2K1 NTRK1 RET TP53
If you have any questions about Circulating Tumor DNA Sequencing at Ayass BioScience, LLC, please call today at 972-668-6005 or fill out our contact form on the bottom of this page. We will answer any question you might have.